Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

TRE17/USP6 oncogene translocated in aneurysmal bone cyst induces matrix metalloproteinase production via activation of NF-κB

Abstract

Aneurysmal bone cyst (ABC) is an aggressive, pediatric bone tumor characterized by extensive destruction of the surrounding bone. Although first described over 60 years ago, its molecular etiology remains poorly understood. Recent work revealed that ABCs harbor translocation of TRE17/USP6, leading to its transcriptional upregulation. TRE17 encodes a ubiquitin-specific protease (USP), and a TBC domain that mediates binding to the Arf6 GTPase. However, the mechanisms by which TRE17 overexpression contributes to tumor pathogenesis, and the role of its USP and TBC domains, are unknown. ABCs are characterized by osteolysis, inflammatory recruitment and extensive vascularization, the processes in which matrix proteases have a prominent role. This led us to explore whether TRE17 regulates the production of matrix metalloproteinases (MMPs). In this study we show that TRE17 is sufficient to induce expression of MMP-9 and MMP-10, in a manner requiring its USP activity, but not its ability to bind Arf6. TRE17 induces transcription of MMP-9 through activation of nuclear factor-κB (NF-κB), mediated in part by the GTPase RhoA and its effector kinase, ROCK. Furthermore, xenograft studies show that TRE17 induces formation of tumors that reproduce multiple features of ABC, including a high degree of vascularization, with an essential role for the USP domain. In sum, these studies reveal that TRE17 is sufficient to initiate tumorigenesis, identify MMPs as novel TRE17 effectors that likely contribute to ABC pathogenesis and define the underlying signaling mechanism of their induction.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Althof PA, Ohmori K, Zhou M, Bailey JM, Bridge RS, Nelson M et al. (2004). Cytogenetic and molecular cytogenetic findings in 43 aneurysmal bone cysts: aberrations of 17p mapped to 17p13.2 by fluorescence in situ hybridization. Mod Pathol 17: 518–525.

    Article  CAS  Google Scholar 

  • Amerik AY, Hochstrasser M . (2004). Mechanism and function of deubiquitinating enzymes. Biochim Biophys Acta 1695: 189–207.

    Article  CAS  Google Scholar 

  • Anwar KN, Fazal F, Malik AB, Rahman A . (2004). RhoA/Rho-associated kinase pathway selectively regulates thrombin-induced intercellular adhesion molecule-1 expression in endothelial cells via activation of I kappa B kinase beta and phosphorylation of RelA/p65. J Immunol 173: 6965–6972.

    Article  CAS  Google Scholar 

  • Barksby HE, Milner JM, Patterson AM, Peake NJ, Hui W, Robson T et al. (2006). Matrix metalloproteinase 10 promotion of collagenolysis via procollagenase activation: implications for cartilage degradation in arthritis. Arthritis Rheum 54: 3244–3253.

    Article  CAS  Google Scholar 

  • Benitah SA, Valeron PF, Lacal JC . (2003). ROCK and nuclear factor-kappaB-dependent activation of cyclooxygenase-2 by Rho GTPases: effects on tumor growth and therapeutic consequences. Mol Biol Cell 14: 3041–3054.

    Article  CAS  Google Scholar 

  • Bernards A . (2003). GAPs galore! A survey of putative Ras superfamily GTPase activating proteins in man and Drosophila. Biochim Biophys Acta 1603: 47–82.

    CAS  PubMed  Google Scholar 

  • Bizimungu C, Thomas A, Brasseur R, Vandenbol M . (2007). Mutational analysis of the TRE2 oncogene encoding an inactive RabGAP. Biotechnol Lett 29: 1927–1937.

    Article  CAS  Google Scholar 

  • Bizimungu C, Vandenbol M . (2005). At least two regions of the oncoprotein Tre2 are involved in its lack of GAP activity. Biochem Biophys Res Commun 335: 883–890.

    Article  CAS  Google Scholar 

  • Bord S, Horner A, Hembry RM, Compston JE . (1998). Stromelysin-1 (MMP-3) and stromelysin-2 (MMP-10) expression in developing human bone: potential roles in skeletal development. Bone 23: 7–12.

    Article  CAS  Google Scholar 

  • Brummelkamp TR, Nijman SM, Dirac AM, Bernards R . (2003). Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature 424: 797–801.

    Article  CAS  Google Scholar 

  • Bryan B, Cai Y, Wrighton K, Wu G, Feng XH, Liu M . (2005). Ubiquitination of RhoA by Smurf1 promotes neurite outgrowth. FEBS Lett 579: 1015–1019.

    Article  CAS  Google Scholar 

  • Cho A, Graves J, Reidy MA . (2000). Mitogen-activated protein kinases mediate matrix metalloproteinase-9 expression in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 20: 2527–2532.

    Article  CAS  Google Scholar 

  • Cottalorda J, Bourelle S . (2007). Modern concepts of primary aneurysmal bone cyst. Arch Orthop Trauma Surg 127: 105–114.

    Article  Google Scholar 

  • Cui R, Tieu B, Recinos A, Tilton RG, Brasier AR . (2006). RhoA mediates angiotensin II-induced phospho-Ser536 nuclear factor kappaB/RelA subunit exchange on the interleukin-6 promoter in VSMCs. Circ Res 99: 723–730.

    Article  CAS  Google Scholar 

  • Engsig MT, Chen QJ, Vu TH, Pedersen AC, Therkidsen B, Lund LR et al. (2000). Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J Cell Biol 151: 879–889.

    Article  CAS  Google Scholar 

  • Genersch E, Hayess K, Neuenfeld Y, Haller H . (2000). Sustained ERK phosphorylation is necessary but not sufficient for MMP-9 regulation in endothelial cells: involvement of Ras-dependent and -independent pathways. J Cell Sci 113 (Pt 23): 4319–4330.

    CAS  PubMed  Google Scholar 

  • Ghajar CM, George SC, Putnam AJ . (2008). Matrix metalloproteinase control of capillary morphogenesis. Crit Rev Eukaryot Gene Expr 18: 251–278.

    Article  CAS  Google Scholar 

  • Giambernardi TA, Grant GM, Taylor GP, Hay RJ, Maher VM, McCormick JJ et al. (1998). Overview of matrix metalloproteinase expression in cultured human cells. Matrix Biol 16: 483–496.

    Article  CAS  Google Scholar 

  • Hacker H, Karin M . (2006). Regulation and function of IKK and IKK-related kinases. Sci STKE 2006: re13.

    Article  Google Scholar 

  • Haeusler G, Walter I, Helmreich M, Egerbacher M . (2005). Localization of matrix metalloproteinases, (MMPs) their tissue inhibitors, and vascular endothelial growth factor (VEGF) in growth plates of children and adolescents indicates a role for MMPs in human postnatal growth and skeletal maturation. Calcif Tissue Int 76: 326–335.

    Article  CAS  Google Scholar 

  • Han S, Ritzenthaler JD, Sitaraman SV, Roman J . (2006). Fibronectin increases matrix metalloproteinase 9 expression through activation of c-Fos via extracellular-regulated kinase and phosphatidylinositol 3-kinase pathways in human lung carcinoma cells. J Biol Chem 281: 29614–29624.

    Article  CAS  Google Scholar 

  • John A, Tuszynski G . (2001). The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol Oncol Res 7: 14–23.

    Article  CAS  Google Scholar 

  • Kanangat S, Postlethwaite A, Hasty K, Kang A, Smeltzer M, Appling W et al. (2006). Induction of multiple matrix metalloproteinases in human dermal and synovial fibroblasts by Staphylococcus aureus: implications in the pathogenesis of septic arthritis and other soft tissue infections. Arthritis Res Ther 8: R176.

    Article  Google Scholar 

  • Kim KC, Lee CH . (2005). MAP kinase activation is required for the MMP-9 induction by TNF-stimulation. Arch Pharm Res 28: 1257–1262.

    Article  CAS  Google Scholar 

  • Komander D, Clague MJ, Urbe S . (2009). Breaking the chains: structure and function of the deubiquitinases. Nat Rev Mol Cell Biol 10: 550–563.

    Article  CAS  Google Scholar 

  • Kovalenko A, Chable-Bessia C, Cantarella G, Israel A, Wallach D, Courtois G . (2003). The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination. Nature 424: 801–805.

    Article  CAS  Google Scholar 

  • Krampert M, Bloch W, Sasaki T, Bugnon P, Rulicke T, Wolf E et al. (2004). Activities of the matrix metalloproteinase stromelysin-2 (MMP-10) in matrix degradation and keratinocyte organization in wounded skin. Mol Biol Cell 15: 5242–5254.

    Article  CAS  Google Scholar 

  • Kumta SM, Huang L, Cheng YY, Chow LTC, Lee KM, Zheng MH . (2003). Expression of VEGF and MMP-9 in giant cell tumor of bone and other osteolytic lesions. Life Sci 73: 1427–1436.

    Article  CAS  Google Scholar 

  • Li M, Chen D, Shiloh A, Luo J, Nikolaev AY, Qin J et al. (2002). Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature 416: 648–653.

    Article  CAS  Google Scholar 

  • Liu J, Zhan M, Hannay JA, Das P, Bolshakov SV, Kotilingam D et al. (2006). Wild-type p53 inhibits nuclear factor-kappaB-induced matrix metalloproteinase-9 promoter activation: implications for soft tissue sarcoma growth and metastasis. Mol Cancer Res 4: 803–810.

    Article  CAS  Google Scholar 

  • Martinu L, Masuda-Robens JM, Robertson SE, Santy LC, Casanova JE, Chou MM . (2004). The TBC (Tre-2/Bub2/Cdc16) domain protein TRE17 regulates plasma membrane-endosomal trafficking through activation of Arf6. Mol Cell Biol 24: 9752–9762.

    Article  CAS  Google Scholar 

  • Masuda-Robens JM, Kutney SN, Qi H, Chou MM . (2003). The TRE17 oncogene encodes a component of a novel effector pathway for Rho GTPases Cdc42 and Rac 1 and stimulates actin remodeling. Mol Cell Biol 23: 2151–2161.

    Article  CAS  Google Scholar 

  • Mott JD, Werb Z . (2004). Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol 16: 558–564.

    Article  CAS  Google Scholar 

  • Nakakuki T, Ito M, Iwasaki H, Kureishi Y, Okamoto R, Moriki N et al. (2005). Rho/Rho-kinase pathway contributes to C-reactive protein-induced plasminogen activator inhibitor-1 expression in endothelial cells. Arterioscler Thromb Vasc Biol 25: 2088–2093.

    Article  CAS  Google Scholar 

  • Nakamura T, Hillova J, Mariage-Samson R, Onno M, Huebner K, Cannizzaro LA et al. (1992). A novel transcriptional unit of the tre oncogene widely expressed in human cancer cells. Oncogene 7: 733–741.

    CAS  PubMed  Google Scholar 

  • Nielsen GP, Fletcher CD, Smith MA, Rybak L, Rosenberg AE . (2002). Soft tissue aneurysmal bone cyst: a clinicopathologic study of five cases. Am J Surg Pathol 26: 64–69.

    Article  Google Scholar 

  • Nobes CD, Hall A . (1995a). Rho, rac and cdc42 GTPases: regulators of actin structures, cell adhesion and motility. Biochem Soc Trans 23: 456–459.

    Article  CAS  Google Scholar 

  • Nobes CD, Hall A . (1995b). Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 81: 53–62.

    Article  CAS  Google Scholar 

  • Oliveira AM, Hsi BL, Weremowicz S, Rosenberg AE, Dal Cin P, Joseph N et al. (2004a). USP6 (Tre2) fusion oncogenes in aneurysmal bone cyst. Cancer Res 64: 1920–1923.

    Article  CAS  Google Scholar 

  • Oliveira AM, Perez-Atayde AR, Dal Cin P, Gebhardt MC, Chen CJ, Neff JR et al. (2005). Aneurysmal bone cyst variant translocations upregulate USP6 transcription by promoter swapping with the ZNF9, COL1A1, TRAP150, and OMD genes. Oncogene 24: 3419–3426.

    Article  CAS  Google Scholar 

  • Oliveira AM, Perez-Atayde AR, Inwards CY, Medeiros F, Derr V, Hsi BL et al. (2004b). USP6 and CDH11 oncogenes identify the neoplastic cell in primary aneurysmal bone cysts and are absent in so-called secondary aneurysmal bone cysts. Am J Pathol 165: 1773–1780.

    Article  CAS  Google Scholar 

  • Onodera S, Nishihira J, Iwabuchi K, Koyama Y, Yoshida K, Tanaka S et al. (2002). Macrophage migration inhibitory factor up-regulates matrix metalloproteinase-9 and -13 in rat osteoblasts. Relevance to intracellular signaling pathways. J Biol Chem 277: 7865–7874.

    Article  CAS  Google Scholar 

  • Panoutsakopoulous G, Pandis N, Kyriazoglou I, Gustafson P, Mertens F, Mandahl N . (1999). Recurrent t{16:17}{q22;p13} in aneurysmal bone cysts. Genes Chromosomes Cancer 26: 265–266.

    Article  Google Scholar 

  • Papa FR, Hochstrasser M . (1993). The yeast DOA4 gene encodes a deubiquitinating enzyme related to a product of the human tre-2 oncogene. Nature 366: 313–319.

    Article  CAS  Google Scholar 

  • Paulding CA, Ruvolo M, Haber DA . (2003). The Tre2 (USP6) oncogene is a hominoid-specific gene. Proc Natl Acad Sci USA 100: 2507–2511.

    Article  CAS  Google Scholar 

  • Pierce JW, Schoenleber R, Jesmok G, Best J, Moore SA, Collins T et al. (1997). Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J Biol Chem 272: 21096–21103.

    Article  CAS  Google Scholar 

  • Rundhaug JE . (2005). Matrix metalloproteinases and angiogenesis. J Cell Mol Med 9: 267–285.

    Article  CAS  Google Scholar 

  • Saccomanni B . (2008). Aneurysmal bone cyst of spine: a review of literature. Arch Orthop Trauma Surg 128: 1145–1147.

    Article  CAS  Google Scholar 

  • Sebban H, Yamaoka S, Courtois G . (2006). Posttranslational modifications of NEMO and its partners in NF-kappaB signaling. Trends Cell Biol 16: 569–577.

    Article  CAS  Google Scholar 

  • Shen C, Ye Y, Robertson SE, Lau AW, Mak DO, Chou MM . (2005). Calcium/calmodulin regulates ubiquitination of the ubiquitin-specific protease TRE17/USP6. J Biol Chem 280: 35967–35973.

    Article  CAS  Google Scholar 

  • Shinde A, Mehlman CT, Collins MH . (2006). Aneurysmal bone cysts express vascular markers. Pediatr Dev Pathol 9: 38–43.

    Article  Google Scholar 

  • Singhal S, Taylor MC, Baker RT . (2008). Deubiquitylating enzymes and disease. BMC Biochem 9 (Suppl 1): S3.

    Article  Google Scholar 

  • Solt LA, Madge LA, Orange JS, May MJ . (2007). Interleukin-1-induced NF-kappaB activation is NEMO-dependent but does not require IKKbeta. J Biol Chem 282: 8724–8733.

    Article  CAS  Google Scholar 

  • Sternlicht MD, Werb Z . (2001). How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17: 463–516.

    Article  CAS  Google Scholar 

  • Subramaniam M, Jalal SM, Rickard DJ, Harris SA, Bolander ME, Spelsberg TC . (2002). Further characterization of human fetal osteoblastic hFOB 1.19 and hFOB/ER alpha cells: bone formation in vivo and karyotype analysis using multicolor fluorescent in situ hybridization. J Cell Biochem 87: 9–15.

    Article  CAS  Google Scholar 

  • Sukov WR, Franco MF, Erickson-Johnson M, Chou MM, Unni KK, Wenger DE et al. (2008). Frequency of USP6 rearrangements in myositis ossificans, brown tumor, and cherubism: molecular cytogenetic evidence that a subset of ‘myositis ossificans-like lesions’ are the early phases in the formation of soft-tissue aneurysmal bone cyst. Skeletal Radiol 37: 321–327.

    Article  Google Scholar 

  • Tolboom TC, Pieterman E, van der Laan WH, Toes RE, Huidekoper AL, Nelissen RG et al. (2002). Invasive properties of fibroblast-like synoviocytes: correlation with growth characteristics and expression of MMP-1, MMP-3, and MMP-10. Ann Rheum Dis 61: 975–980.

    Article  CAS  Google Scholar 

  • Trompouki E, Hatzivassiliou E, Tsichritzis T, Farmer H, Ashworth A, Mosialos G . (2003). CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members. Nature 424: 793–796.

    Article  CAS  Google Scholar 

  • Van den Steen PE, Dubois B, Nelissen I, Rudd PM, Dwek RA, Opdenakker G . (2002). Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit Rev Biochem Mol Biol 37: 375–536.

    Article  CAS  Google Scholar 

  • Vu TH, Shipley JM, Bergers G, Berger JE, Helms JA, Hanahan D et al. (1998). MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93: 411–422.

    Article  CAS  Google Scholar 

  • Wang D, Christensen K, Chawla K, Xiao G, Krebsbach PH, Franceschi RT . (1999). Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential. J Bone Miner Res 14: 893–903.

    Article  CAS  Google Scholar 

  • Wang HR, Ogunjimi AA, Zhang Y, Ozdamar B, Bose R, Wrana JL . (2006). Degradation of RhoA by Smurf1 ubiquitin ligase. Meth Enzymol 406: 437–447.

    Article  CAS  Google Scholar 

  • Wang HR, Zhang Y, Ozdamar B, Ogunjimi AA, Alexandrova E, Thomsen GH et al. (2003). Regulation of cell polarity and protrusion formation by targeting RhoA for degradation. Science 302: 1775–1779.

    Article  CAS  Google Scholar 

  • Welman A, Cawthorne C, Ponce-Perez L, Barraclough J, Danson S, Murray S et al. (2006). Increases in c-Src expression level and activity do not promote the growth of human colorectal carcinoma cells in vitro and in vivo. Neoplasia 8: 905–916.

    Article  CAS  Google Scholar 

  • Wertz IE, O'Rourke KM, Zhou H, Eby M, Aravind L, Seshagiri S et al. (2004). De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 430: 694–699.

    Article  CAS  Google Scholar 

  • Yamaguchi T, Kimura J, Miki Y, Yoshida K . (2007). The deubiquitinating enzyme USP11 controls an IkappaB kinase alpha (IKKalpha)-p53 signaling pathway in response to tumor necrosis factor alpha (TNFalpha). J Biol Chem 282: 33943–33948.

    Article  CAS  Google Scholar 

  • Zhong H, SuYang H, Erdjument-Bromage H, Tempst P, Ghosh S . (1997). The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell 89: 413–424.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by the NIH Grants CA081415 (MMC), DK58044 (GAB) and P30 AR050950 (Penn Center for Musculoskeletal Disorders). Additional support was from the Mayo Foundation CR20 Program (AMO), the Pennsylvania Muscle Institute Pilot Project Grant (MMC) and the Pennsylvania Department of Health (MMC), which specifically disclaims responsibility for any analysis, interpretations or conclusions. We thank Yvette Liu for invaluable assistance with bioluminescence imaging.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M M Chou.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the Oncogene website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ye, Y., Pringle, L., Lau, A. et al. TRE17/USP6 oncogene translocated in aneurysmal bone cyst induces matrix metalloproteinase production via activation of NF-κB. Oncogene 29, 3619–3629 (2010). https://doi.org/10.1038/onc.2010.116

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2010.116

Keywords

This article is cited by

Search

Quick links